Dme.Ax
DME.AX operates in the Diversified Mining industry, extracting and processing a range of minerals and metals, and generates revenue primarily through the sale of these commodities.
Business. DME.AX operates in the Diversified Mining industry, extracting and processing a range of minerals and metals, and generates revenue primarily through the sale of these commodities.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
DME.AX operates in the Diversified Mining industry, extracting and processing a range of minerals and metals, and generates revenue primarily through the sale of these commodities.
DME.AX exhibits a capital structure with a very low debt-to-equity ratio of 0.01, indicating a strong equity position relative to its liabilities. The company's liquidity is characterized by a current ratio of 2.35, suggesting it has sufficient short-term assets to cover its short-term obligations. However, the company's operating cash flow is negative at -2.802 million AUD, and its free cash flow is also negative at -5.312 million AUD, indicating a lack of cash generation from operations.
Profitability metrics for DME.AX are significantly negative, with a return on equity of -13.23% and a return on assets of -12.95%. These figures are well below the industry median for the Diversified Mining sector, which typically sees positive returns in a stable commodity price environment. The company's operating income is -4.549 million AUD, and its net income is -4.625 million AUD, reflecting a challenging operating environment.
DME.AX's revenue is not segmented by geographic region or product line in the available data, but the company's exposure to the mining industry suggests a concentration in the commodities it produces. The company's revenue concentration is not explicitly quantified, but the negative operating and net income figures suggest a lack of diversification in revenue streams or pricing power.
The company's growth trajectory is negative, with a current revenue of 4.220 million AUD. The outlook for the current fiscal year and the next fiscal year is not provided in the available data, but the negative operating and net income figures suggest a lack of growth momentum. The company's capital expenditure of -712,420 AUD indicates a reduction in investment in new projects or equipment, which could further limit growth potential.
DME.AX faces a medium liquidity risk, as indicated by the risk assessment, and a low dilution risk. The company's net cash is negative after subtracting total debt, which could impact its ability to fund operations or invest in growth opportunities. The dilution potential is low, and no adjustments have been applied to the valuation metrics, suggesting that the company's capital structure is stable.
Recent events for DME.AX are not detailed in the available data, but the company's financial performance suggests a challenging operating environment. The negative operating and net income figures, combined with the negative cash flows, indicate a need for strategic adjustments to improve profitability and cash generation.
- DME.AX has a strong equity position but is experiencing significant negative profitability and cash flow.
- The company's return on equity and return on assets are well below industry norms, indicating poor performance.
- DME.AX's liquidity is adequate, but its negative operating and free cash flows suggest a lack of cash generation.
- The company's growth trajectory is negative, with no clear signs of improvement in the near term.
- DME.AX faces a medium liquidity risk and a low dilution risk, but its financial performance indicates a need for strategic adjustments.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- DME.AX Market data — financials · 2026-05-27